Simon Kohl, a former DeepMind scientist instrumental in AlphaFold's development, has launched Latent Labs, a startup focused on utilizing AI for protein design. The company raised $50 million, led by Radical Ventures and backed by notable tech figures. Latent Labs aims to transform drug discovery by replacing conventional experimental methods with computational approaches. Kohl envisions creating new proteins through generative AI, enhancing the efficacy of drug development. The startup is building a talented team, including former DeepMind researchers, to push the boundaries of biotech innovation.
Kohl's vision with Latent Labs is to leverage AI to innovate protein design, aiming to streamline and enhance the traditional processes of drug discovery.
With $50 million in funding, Latent Labs plans to replace experimental methods in biotech with AI tools for faster, more precise drug development.
Collection
[
|
...
]